Beijing Scitop Bio-tech Co., Ltd. (SHE:300858)

Beijing Scitop Bio-tech Revenue

Beijing Scitop Bio-tech had revenue of 97.14M CNY in the quarter ending September 30, 2026, a decrease of -6.63%. This brings the company's total for the last twelve months to 365.18M, up 3.90% year-over-year. In the year 2025, Beijing Scitop Bio-tech had annual revenue of 365.92M with 20.85% growth. That makes Beijing Scitop Bio-tech the 27,325th largest company in the world by revenue and 4,746th in China.

• Revenue (ttm): 365.18M
• Revenue Growth: +3.90%
• P/S Ratio: 9.78
• Revenue / Employee: 884.22K
• Employees: 413
• Market Cap: 3.57B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Edible Probiotic Products 264.58M 72.3%
• Animal and Plant Microecological Preparation 60.70M 16.6%
• Compound Food Additives 36.32M 9.9%
• Probiotics Technical Services 3.33M 0.9%
• Other 985.50K 0.3%

Fiscal year ended Dec 31, 2025 See the full Beijing Scitop Bio-tech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	365.92M	63.13M	20.85%
Dec 31, 2024	302.79M	3.55M	1.19%
Dec 31, 2023	299.24M	-69.92M	-18.94%
Jan 1, 2023	369.17M	4.55M	1.25%
Dec 31, 2021	364.62M	25.46M	7.51%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error